Inflammation: Roles in Skeletal Muscle Atrophy

Area of Science:

• Biomedical Science
• Molecular Biology
• Physiology

Background:

• Skeletal muscle atrophy is a complex condition linked to various diseases, often involving inflammation, mitochondrial dysfunction, and altered protein metabolism.
• The precise mechanisms of inflammation-induced muscle atrophy are not fully understood, limiting effective therapeutic interventions.

Purpose of the Study:

• To review the intricate mechanisms of skeletal muscle atrophy, focusing on the role of inflammation.
• To elucidate the signaling pathways involved in inflammation-driven muscle wasting and explore potential therapeutic targets.

Main Methods:

• Comprehensive review of existing literature on protein degradation systems (UPS, ALP, calpains, caspases) and protein synthesis pathways (IGF-1/Akt).
• Analysis of inflammatory signaling cascades (NF-κB, p38MAPK, JAK/STAT) and their interaction with muscle atrophy.
• Exploration of indirect effects of inflammation on skeletal muscle via the HPA axis and fat metabolism.

Main Results:

• Inflammation directly activates key signaling pathways, leading to increased protein breakdown and decreased synthesis in skeletal muscle.
• Systemic inflammatory conditions (cachexia, sepsis, T2DM, obesity, COPD, CKD, nerve injury) are associated with muscle atrophy.
• Changes in the hypothalamic-pituitary-adrenal axis and fat metabolism under inflammation exacerbate muscle wasting.

Conclusions:

• Inflammation is a central etiological factor in skeletal muscle atrophy.
• Anti-inflammatory strategies targeting specific inflammatory factors and their downstream pathways represent a promising therapeutic approach for muscle atrophy.